FDA REdI Annual Conference
Conference Focus
FDA regulatory education for drugs, devices, biologics
Overview
The FDA Regulatory Education for Industry (REdI) Annual Conference is a premier event organized directly by the U.S. Food and Drug Administration. It serves as a critical bridge between the agency and the regulated industry, providing comprehensive education on the latest regulatory requirements, policies, and guidance for drugs, medical devices, and biologics. The conference is designed to foster a deeper understanding of the regulatory landscape, ensuring that industry professionals are equipped to navigate complex compliance pathways effectively. What makes this conference unique is its direct access to FDA subject matter experts. Attendees gain firsthand insights into the agency's current thinking, priorities, and evolving regulatory strategies. By covering a broad spectrum of topics—from pre-market submissions to post-market safety—the event plays a vital role in enhancing industry-wide compliance, promoting public health, and facilitating the development of innovative medical products.
Why Attend
Professionals should attend to gain direct, authoritative guidance from FDA regulators, reducing uncertainty in compliance and submission processes. It offers unparalleled networking with both agency officials and industry peers, providing strategic value for navigating regulatory hurdles. Attendees will walk away with actionable knowledge on current FDA expectations, helping to streamline product development timelines and improve the quality of regulatory filings.
Key Topics & Sessions
- •Drug Development and Approval Processes
- •Medical Device Regulatory Pathways
- •Biologics and Biosimilars Regulation
- •Post-Market Safety and Pharmacovigilance
- •Quality Systems and Compliance
- •Clinical Trial Design and Conduct
- •Emerging Regulatory Technologies
- •FDA Guidance and Policy Updates
- •International Harmonization Efforts
- •Combination Products Regulation
Who Should Attend
Conference History
The FDA REdI program was established to provide accessible regulatory training to the industry. Over the years, it has evolved from localized workshops into a major annual hybrid event, significantly expanding its reach to global audiences and becoming a cornerstone for FDA-industry engagement.
Venue & Location
FDA White Oak Campus, Silver Spring, MD. The event utilizes a hybrid format, offering both in-person attendance and a robust virtual platform for remote participation.
Related Conference Categories
This conference covers topics in the following pharma and life sciences domains. Explore more events in each category using our conference directory filters.
Resources & Links
About FDA REdI Annual Conference
FDA REdI Annual Conference is a hybrid event scheduled for 2026-05-19 to 2026-05-20 in FDA White Oak Campus, Silver Spring, MD. The conference focuses on fda regulatory education for drugs, devices, biologics. This event is categorized under Regulatory & Compliance in our conference directory.
The FDA Regulatory Education for Industry (REdI) Annual Conference is a premier event organized directly by the U.S. Food and Drug Administration. It serves as a critical bridge between the agency and the regulated industry, providing comprehensive education on the latest regulatory requirements, policies, and guidance for drugs, medical devices, and biologics. The conference is designed to foster a deeper understanding of the regulatory landscape, ensuring that industry professionals are equipped to navigate complex compliance pathways effectively. What makes this conference unique is its direct access to FDA subject matter experts. Attendees gain firsthand insights into the agency's current thinking, priorities, and evolving regulatory strategies. By covering a broad spectrum of topics—from pre-market submissions to post-market safety—the event plays a vital role in enhancing industry-wide compliance, promoting public health, and facilitating the development of innovative medical products.
Professionals attending conferences like FDA REdI Annual Conference gain access to cutting-edge insights, peer networking, and exposure to the latest technologies shaping the pharmaceutical and biotechnology sectors. Whether you are evaluating new vendors, seeking regulatory updates, or expanding your professional network, industry conferences remain one of the most effective ways to stay current in life sciences.
Regulatory conferences are essential for staying current with evolving requirements from the FDA, EMA, and other global regulatory bodies. Understanding compliance frameworks such as 21 CFR Part 11 and ICH guidelines is critical for pharmaceutical software development and validation.
Looking for guidance on which conferences to attend or how to build your event strategy for 2026? Book a meeting with the IntuitionLabs team to discuss your priorities and how we can support your team.